Sepideh Gholami, Liver and Pancreas Surgeon-Scientist at Northwell Health and Cold Spring Harbor Laboratory, shared a post on LinkedIn:
“Proof of our resident presentation at American Society of Clinical Oncology (ASCO) GI26 on our IIT using an implantable microdevice to test novel immunotherapy combinations and sequencing in real time. Excited to be doing this in collaboration with Agenus and pushing translational IO science forward.”
Dhan Chand, Vice President of Research at Agenus, shared this post, adding:
“Novel combinations and bold thinking are the catalysts that will unlock new treatment paradigms and redefine what’s possible for patients with the most difficult-to-treat cancers.”
More posts featuring Sepideh Gholami and Dhan Chand on OncoDaily.